How many patents does
Genmab have?
patents
810
families
85
granted
174
applications
636
US
145
EP
102
JP
67
WO
61
CN
51
KR
32
RoW
352
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Genmab
Top ten assignees appearing on patents
2009 - 2018
| genmab | 645 |
| international - drug - development… 🛈 | 11 |
| biontech company | 10 |
| cormorant pharmaceuticals | 8 |
| genmab holding | 1 |
| medarex | 1 |
| genmab b v | 1 |
2009
| genmab | 39 |
2018
| genmab | 90 |
| biontech company | 4 |
| cormorant pharmaceuticals | 3 |
| medarex | 1 |
Genmab
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| antibodies against cd38 for treatment of multiple myeloma | 61 | 2005 |
| human monoclonal antibodies against cd20 | 42 | 2002 |
| human antibodies against tissue factor | 39 | 2008 |
| monoclonal antibodies against c-met | 35 | 2010 |
| human antibody drug conjugates against tissue factor | 35 | 2010 |
| heterodimeric antibody fc-containing proteins and methods for production thereof | 23 | 2010 |
| antibody variants and uses thereof | 23 | 2011 |
| monoclonal antibodies against her2 | 21 | 2010 |
| bispecific antibodies and methods for production thereof | 21 | 2007 |
| bispecific antibodies against her2 and cd3 | 21 | 2010 |